Alcon CHF 0.20 PAR VALUE
ACL
ACL was delisted on the 8th of April, 2011.
2 hedge funds and large institutions have $14.1M invested in Alcon CHF 0.20 PAR VALUE in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
8,364,610% more capital invested
Capital invested by funds: $168 → $14.1M (+$14.1M)
100% more funds holding
Funds holding: 1 → 2 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NPA
Nichols & Pratt Advisers
Boston,
Massachusetts
|
+$14.1M |
Top Sellers
ACL Hedge Fund Activity: Q2 2023 in Review
2 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Alcon CHF 0.20 PAR VALUE (ACL) for Q2 2023, worth a combined $14.1M — up 8,364,610% from $168 a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new ACL positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Nichols & Pratt Advisers, opening a new position worth an estimated $14.1M.
- 2 institutional investors held Alcon CHF 0.20 PAR VALUE (ACL) as of Q2 2023, up from 1 in Q1 2023.
- Funds reported $14.1M of Alcon CHF 0.20 PAR VALUE stock for Q2 2023, up 8,364,610% quarter-over-quarter.
- 1 fund opened new Alcon CHF 0.20 PAR VALUE positions in Q2 2023 and 0 closed out, a net change of +1 holder.
- The largest Alcon CHF 0.20 PAR VALUE buyer in Q2 2023 was Nichols & Pratt Advisers, an estimated $14.1M added.
Based on aggregated 13F filings for Q2 2023.